September 2008
Advertisement
Advertisement
Trending on HCPLive
1
Bimekizumab Data Support Case for Earlier Intervention in HS
2
Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy
3
Rethinking HFpEF Screening and Care, With Ronald D'Agostino, DO
4
BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS
5